Class ITerminatedD-0104-2018
Drug recall · December 13, 2017
PapaZen 3300 capsule recall
Why: Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
PapaZen 3300 capsule, Proprietary Blend 1800mg, 1-capsule packets, distributed by FX Power San Diego, CA 92108, UPC 718122032587
- Lots / codes
Lot# NSS050888, EXP 05-2018
- Quantity
- 89 1-capsule packets
- Company
- Gadget Island, Inc, Newark, CA
- Distribution
- Nationwide in the USA
- Initiated
- September 15, 2017 · Voluntary: Firm initiated
- Classified
- December 4, 2017
- Reported
- December 13, 2017
- Ended
- December 4, 2018
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.